reference/32458450

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32458450

Outgoing Links

Predicate	Object
contentType	Journal Article\|Meta-Analysis\|Systematic Review
issn	1472-6882
issueIdentifier	1
pageRange	178-
publicationName	BMC Complementary and Alternative Medicine
startingPage	178
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_468ccf43b1fe31f2b70417f0f13a80c0 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_20ceaf027a1e30e852fd822c55fe21a0 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0cf8dd5f4f6149c8504bc5644c636ab8 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_49cc76ee43e37921fa61d268731e34e6 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_017f8d796530e62fab86073ecc7dceaa http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0906a516f0ce0bc03df8b408420de749 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0c2cd38b6617434252e5c4691f3fef8d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b2ac123d4c428d7db23eb04f59b6d068 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_3b6c7b911835a07131ba7cdd511006ae http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_dcbe4b9738ec87f5d8081f00d143704e http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_68d24967eaf79370d93ad80db300bbb3 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_82ebdedd02fbc2a689d843a7124be272
bibliographicCitation	Cai Y, Liang Q, Chen W, Chen M, Chen R, Zhang Y, Xiao Y, Chen L. Evaluation of HuoXueHuaYu therapy for nonalcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trial. BMC Complementary Medicine and Therapies. 2019 Jul 19;19(1):178. doi: 10.1186/s12906-019-2596-3.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fa5e77af0af809d18499a9d781cb8ce6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a2f6e0cb5fd801f2496759086a0b7f05 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4158162294575577f0f39af5f6c6e5df http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f424ed5089a4eb64a40fab58f93ad1fb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7de8e4538d8efaabce127e2ce33db27f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb6a3a5ae903c51979d2fd9ab74c464a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_526fe7ce54e2c7f4c86e9b3c9cea711f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9137fe389d3788dfc8786b5f58f9a09a
date	2019-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC6642602 https://doi.org/10.1186/s12906-019-2596-3 https://pubmed.ncbi.nlm.nih.gov/31324247
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22339 https://portal.issn.org/resource/ISSN/1472-6882
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ https://scigraph.springernature.com/
title	Evaluation of HuoXueHuaYu therapy for nonalcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trial
discusses	http://id.nlm.nih.gov/mesh/M0006858 http://id.nlm.nih.gov/mesh/M0021969
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11475 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460048 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.6.1.1 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_aeebd1980c6662678028fc899ba441eb http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.6.1.2

Total number of triples: 46.